BIAF (bioAffinity Technologies Inc.) Net earnings per share (EPS TTM)

Symbol and logo of brand bioAffinity Technologies Inc. (BIAF)

bioAffinity Technologies (BIAF) is developing the Physiocist AI system for rapid sputum analysis, creating a closed diagnostic loop. The 12-month net income per share trend allows for an assessment of this model's scalability, where -38.42 determines the latest valuation metric. A stable team of oncologist-developers and the company's status as a recognized expert in non-invasive screening provide bioAffinity Technologies with long-term growth potential.

BIAF (bioAffinity Technologies) Net earnings per one share for the last twelve months history from 04/28/2023 to 11/11/2026

bioAffinity Technologies Inc. - analytical breakdowns and key metrics (BIAF)

- current quotes and average value forecast:
Price Chart bioAffinity|BIAF - Broker Consensus Forecast
- business market valuation indicators:
Market Capitalization bioAffinity Technologies, Inc.|BIAF - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share bioAffinity Technologies|BIAF - Total Stockholders' Equity|Market Value to Book Value Ratio bioaffinitytech.com|BIAF - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital bioAffinity Technologies|BIAF - Long-Term Debt to Equity|Short-Term Debt to Capital bioAffinity|BIAF - Company Total Debt Obligations|Debt to Book Capitalization Ratio bioAffinity Technologies, Inc.|BIAF - Long-Term Debt|Company Short-Term Debts bioAffinity Technologies|Quick Ratio bioaffinitytech.com
- net income and valuation multiples indicators:
BIAF - Profit After Tax|Projected Future Earnings bioAffinity Technologies|BIAF - Market Cap to Net Income|Forward P/E Multiple bioAffinity|BIAF - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization bioAffinity Technologies, Inc.|BIAF - Operating profit before amortization|Net earnings per share (EPS TTM) bioAffinity Technologies|BIAF - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months bioaffinitytech.com|BIAF - Net earnings per one share growth for the current year|Expected earnings per share growth for next year bioAffinity Technologies
Fundamental company analysis:BIAF - bioaffinitytech.com
Manufactured products of bioAffinity Technologies Inc.

Conservative asset selection requires an analysis of the actual return on each share of capital. This indicator calculates the total annual net income divided by the total number of shares, excluding the volatility of quarterly reports. For bioAffinity Technologies (BIAF), this parameter is critical, as challenges with test implementation and insurance coverage directly impact profitability. The trailing twelve months (TTM) net income per share trend reflects the fundamental stability of the business.

Main competitors

AVBP - Earnings per share for the last twelve months|LTRN (Lantern Pharma Inc.) - Earnings per share for the last 12 months|EFTR: Net earnings per share (EPS TTM)